Cullinan Therapeutics, Inc. CGEM
Set alert
14.93 USD -0.10 -0.67%
At close
14.60 -0.33 -2.21%
Pre-market · Nov 3, 7:12 AM ET
14.63 Day range 15.35
6.73 52-week range 23.19
- YTD
- +44.25%
- 1 year
- +72.40%
- Open
- 15.13
- Prev close
- 15.03
- Mkt cap
- 917.57M
- Vol
- 730.77K
- Avg vol
- 903.67K
- EPS
- -3.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.63
- High
- 15.35
- Forward P/E
- -6.30
- Beta
- -0.04
- Short ratio
- 6.17
- Inst. own
- 112.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.28
- 200-d avg
- 15.74
- 1y target
- 34.60
YTD chart
Events in this range
- Mar 10, 2026Earnings: -0.77; estimate -0.8; surprise 3.75%
- May 7, 2026Earnings: -0.75; estimate -0.83588; surprise 10.27%
- Aug 6, 2026Earnings: -0.81; estimate -0.79931; surprise -1.34%
- Sep 14, 2026Rating: BTIG · Buy → Buy
- Sep 25, 2026Rating: BTIG · Buy → Buy
- Sep 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 19, 2026Rating: BTIG · Buy → Buy
- Oct 28, 2026Rating: BTIG · Buy → Buy
Signals (44)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
Newest 20 of 44.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 34.60 +131.7% upside
Now 14.93
- Target (low)
- 27.00
- Target (mean)
- 34.60
- Target (high)
- 42.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
- Strong buy1
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.83991 | -1.04 – -0.71 | -0.77 | -9.1% | 0 | 0.0% | 9 |
| Next quarter | -0.69919 | -1.16 – 0.71373 | -0.77 | +9.2% | 11.56M | 0.0% | 9 |
| Current year | -3.13 | -3.79 – -1.85 | -3.36 | +7.0% | 13.88M | 0.0% | 9 |
| Next year | -2.47 | -3.93 – -1.25 | -3.13 | +20.9% | 55.51M | +300.0% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 19, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 25, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 25, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 14, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 29, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 11, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jun 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 19, 2026 | BTIG | Reiterated | Buy | Buy |
| May 8, 2026 | Wedbush | Maintained | Outperform | Outperform |
| May 4, 2026 | BTIG | Reiterated | Buy | Buy |
| Apr 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 28, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 11, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 17, 2026 | Citigroup | Initiated | — | Buy |
| Feb 2, 2026 | Guggenheim | Initiated | — | Buy |
| Jan 8, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 9, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Nov 20, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 12, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 10, 2025 | BTIG | Reiterated | Buy | Buy |
| Aug 18, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 12, 2025 | UBS | Maintained | Buy | Buy |
| Apr 16, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2025 | Stifel | Maintained | Buy | Buy |
| Oct 24, 2024 | UBS | Initiated | — | Buy |